Beta Pharmaceuticals Limited
Registered name: BETA PHARMACEUTICALS LIMITED
Beta Pharmaceuticals Limited made £34.3m revenue and £120k profit in the year to 30 Sep 2025.
Beta Pharmaceuticals Limited’s revenue grew 16% to £34.3m in the year to 30 Sep 2025, with £120k profit and 61 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Witham; we hold 2 years of its filed accounts.
- Status
- Active
- Location
- Witham, East of England
- Age
- 22 yrs · since 2003
- Type
- Private Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 30 Sep 2024 | 30 Sep 2025 |
|---|---|---|
| Disclosure | Full P&L | Full P&L |
| Profit & loss | ||
| Revenue (turnover) | £29.6m | £34.3m |
| Operating profit | £116k | £189k |
| Profit before tax | £112k | £172k |
| Profit after tax | £75k | £120k |
| Profit (best available) | £75k | £120k |
| Staff costs | £1.5m | £1.4m |
| Employees (average) | 61 | 61 |
| Ratios | ||
| Profit margin | 0.3% | 0.4% |
| Revenue per employee | £485k | £563k |
| Profit per employee | £1.2k | £2k |
| Cash conversion | −755.6% | 303.9% |
| Growth (year on year) | ||
| Revenue growth | — | ▲16.1% |
| Profit growth | — | ▲60.3% |
| Headcount growth | — | 0% |
| Balance sheet — indirect signals, not revenue | ||
| Cash at bank | £1.3k | £604 |
| Net assets | £9.1m | £9.3m |
| Fixed assets | £177k | £142k |
| Current assets | £11m | £10.8m |
| Debtors | £8.1m | £8.3m |
| Cash from operations | −£879k | £573k |
| Source | FullAccounts · bulk data Jun 2026 | FullAccounts · bulk data Jun 2026 |
How the business works
- Profit margin
- 0.4%
- Profit ÷ revenue.
- Gross margin
- —
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £563k
- Revenue ÷ average employees.
- Profit per employee
- £2k
- Profit ÷ average employees.
- Cash conversion
- 303.9%
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 0.4%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 24.1%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲1%
- Now £9.3m
- Cash at bank
- ▼53%
- Now £604
- Headcount
- 0%
- Now 61
- Deferred income
- —
- Now —
- Fixed assets
- ▼20%
- Now £142k
Similar profitable businesses
- Ims Euro LimitedStockport · Wholesale of pharmaceutical goods
- Revenue
- £32.9m
- Profit
- £5.5m
- Staff
- 83
- Paul Murray PLCSouthampton · Wholesale of pharmaceutical goods
- Revenue
- £32.9m
- Profit
- £1.7m
- Staff
- 92
- Attends LimitedWakefield · Wholesale of pharmaceutical goods
- Revenue
- £35.9m
- Profit
- £635k
- Staff
- 23
- New England Biolabs (U.K.) LimitedHitchin · Wholesale of pharmaceutical goods
- Revenue
- £36m
- Profit
- £1.8m
- Staff
- 44
- Medreich PLCFeltham · Wholesale of pharmaceutical goods
- Revenue
- £32.7m
- Profit
- £440k
- Staff
- 32
- Bowmed Ibisqus LimitedManchester · Wholesale of pharmaceutical goods
- Revenue
- £32m
- Profit
- £3.4m
- Staff
- 11
Sources
Latest figures from FullAccounts for the year to 30 Sep 2025 (profit £120k), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.